RecruitingNCT04965545
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
1,000 participants
Start Date
Jan 1, 2004
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up
Eligibility
Min Age: 6 YearsMax Age: 65 Years
Inclusion Criteria1
- genetically diagnosed patients with wilson disease
Exclusion Criteria1
- Deny follow-up
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTlow copper diet
All patients with wilson disease should receive low copper diet
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04965545
Related Trials
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
NCT072266227 locations
Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study
NCT073012161 location
Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity
NCT069450812 locations
A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
NCT066503191 location
Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients
NCT064303591 location